FDA of­fers guid­ance for gener­ic drug de­vel­op­ers of hy­drox­y­chloro­quine, chloro­quine

The FDA on Mon­day is­sued two new prod­uct-spe­cif­ic guid­ance doc­u­ments for the un­proven but high­ly de­mand­ed po­ten­tial Covid-19 drugs chloro­quine phos­phate and hy­drox­y­chloro­quine sul­fate. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER